There was a sharp spike in the price of ALKS - more to come? Feb-17-18 3 Biotech Stocks That Soared This Week: Are They Buys? Motley Fool Feb-16-18 Alkermes PLC (ALKS) Files 10-K for the Fiscal Year Ended on December 31, 2017 GuruFocus.com +5.51% Feb-16-18 Blog Exposure - FDA Accepted New Drug Application Submitted by Valeant Pharma's Ortho Dermatologics for JEMDEL(TM) Plaque Psoriasis Treatment ACCESSWIRE Feb-15-18 Alkermes (ALKS) Beats Q4 Earnings, Revenue Estimates Zacks +7.52%
Looks like the short term punters are running for the hills - time for serious informed investors to take another look?
This one is going to be a rocky ride at the best of times! I am certainly no expert on pharmaceuticals but FDA acceptance of a new drug is not easy to achieve. This is one for the traders in the short term!